While the plasma test is a rapid, minimally invasive, and inexpensive method with high accuracy for AD, particularly when combined with age and ApoE e4 carrier status [95,96,97], studies are needed for CAA in humans. The gene discussed is APOE; the disease is Alzheimer disease.